Skip to content

IMTX - Immatics N.V. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchI

Immatics NV

IMTX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

I

IMTXImmatics NV

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $12.41
52-wk low: $5.05
Prev close: $9.19
Mkt cap: $1.26B
Beta: 1.32
P/S: 33.9x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$51.2M

CI
Citadel
Ken Griffin · Q2 2026 13F
$18.4M
position
P7
Point72
Steven Cohen · Q2 2026 13F

Earnings

Reported Aug 12, 2026

Earnings came in 23.3% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $1.3B

Valuation

P/S33.90
P/B2.68

Quality

Operating margin-868.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: IMTX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $1.26B
Beta: 1.32

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

2.7x

Profit margin

+0.0%

Op margin

-868.0%

ROE

-43.2%

$14.7M

position

QR

Qube Research

Q2 2026 13F

$5.3M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for IMTX

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.53-23.3%

-$0.43 expected

Next report

What the street expects next

EPS expected

-$0.49

-$0.59 to -$0.36

Revenue expected

$11.9M

8 analysts

Last 30 days

4up4down

Split both ways

Estimate drift

+0.01

Change in 30 days

-43.2%

ROA-22.4%

Growth

Beta1.32